Pacira BioSciences (PCRX) Assets (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Assets of $1.2 billion for Q1 2026, down 23.83% year-over-year from $1.6 billion in Q1 2025, and down 4.46% quarter-over-quarter from $1.3 billion in Q4 2025.
Pacira BioSciences (PCRX) Assets (2010 - 2026) Analysis & Trends
Pacira BioSciences' Assets history runs 17 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- In Q1 2026, Assets fell 23.83% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (down 23.83% YoY), while the FY2025 annual figure was $1.3 billion, down 18.58% from the prior year.
- Assets for Q1 2026 stood at $1.2 billion, down from $1.3 billion in the prior quarter.
- The five-year high for Assets was $1.9 billion in Q1 2022, with the low at $1.2 billion in Q1 2026.
- The 5-year median for Assets is $1.6 billion (2024), against an average of $1.6 billion.
- The sharpest annual moves came in 2022 and 2026: Assets soared 46.91% in 2022, then slipped 23.83% in 2026.
- Pacira BioSciences' Assets stood at $1.7 billion in 2022, then fell by 6.35% to $1.6 billion in 2023, then retreated by 1.33% to $1.6 billion in 2024, then declined by 18.58% to $1.3 billion in 2025, then dropped by 4.46% to $1.2 billion in 2026.
- Business Quant data shows PCRX's Assets at $1.2 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 6.18 Bn |
| 10 | Pacira BioSciences | 945.90 Mn | 694.87 Mn | 148.24 Mn | 1.24 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.24 Bn |
| Mar 31, 2026 | 1.21 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Sep 30, 2025 | 1.30 Bn |
| Jun 30, 2025 | 1.54 Bn |
| Mar 31, 2025 | 1.59 Bn |
| Dec 31, 2024 | 1.55 Bn |
| Sep 30, 2024 | 1.52 Bn |
| Jun 30, 2024 | 1.65 Bn |
| Mar 31, 2024 | 1.58 Bn |
| Dec 31, 2023 | 1.57 Bn |
| Sep 30, 2023 | 1.53 Bn |
| Jun 30, 2023 | 1.54 Bn |
| Mar 31, 2023 | 1.52 Bn |
| Dec 31, 2022 | 1.68 Bn |
| Sep 30, 2022 | 1.73 Bn |
| Jun 30, 2022 | 1.73 Bn |
| Mar 31, 2022 | 1.89 Bn |
| Dec 31, 2021 | 2.08 Bn |
| Sep 30, 2021 | 1.36 Bn |